CAIN CHRISTOPHER W.
SEC insider (Form 3/4/5 filer). CIK 0001817733. Director at Viridian Therapeutics, Inc.\DE (VRDN) and 3 other issuers. 8 reported Form 4/5 transactions since Sep 2024; latest on Jul 1, 2026. Located in WALTHAM, MA.
Companies CAIN CHRISTOPHER W. has filed insider reports for
- Viridian Therapeutics, Inc.\DE (VRDN): Director
- Jade Biosciences, Inc. (JBIO): Director
- Cogent Biosciences, Inc. (COGT): Director
- Damora Therapeutics, Inc. (DMRA): Director
CAIN CHRISTOPHER W.
CIK: 0001817733
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Jul 1, 2026VRDN
Viridian Therapeutics, Inc.\DE
AwardIndirectStock Option (Right to Buy)
32.3K shares- - Jun 9, 2026JBIO
Jade Biosciences, Inc.
AwardDirectStock Option (Right to Buy)
34.8K shares- - Jun 9, 2026COGT
Cogent Biosciences, Inc.
AwardDirectStock Option (Right to Buy)
17.9K shares- - Mar 23, 2026DMRA
Damora Therapeutics, Inc.
AwardDirectStock Option (right to buy)
37.3K shares- - Jul 1, 2025VRDN
Viridian Therapeutics, Inc.\DE
AwardIndirectStock Option (Right to Buy)
21K shares- - Jun 4, 2025COGT
Cogent Biosciences, Inc.
AwardDirectStock Option (Right to Buy)
44.7K shares- - Apr 29, 2025JBIO
Jade Biosciences, Inc.
AwardDirectStock Option (Right to Buy)
23K shares- - Mar 10, 2025VRDN
Viridian Therapeutics, Inc.\DE
AwardIndirectStock Option (Right to Buy)
42K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 1, 2026 |  VRDN Viridian Therapeutics, Inc.\DE | Award Stock Option (Right to Buy) | 32,341 | - | - | Indirect |
| Jun 9, 2026 |  JBIO Jade Biosciences, Inc. | Award Stock Option (Right to Buy) | 34,843 | - | - | Direct |
| Jun 9, 2026 |  COGT Cogent Biosciences, Inc. | Award Stock Option (Right to Buy) | 17,901 | - | - | Direct |
| Mar 23, 2026 |  DMRA Damora Therapeutics, Inc. | Award Stock Option (right to buy) | 37,313 | - | - | Direct |
| Jul 1, 2025 | VRDN Viridian Therapeutics, Inc.\DE | Award Stock Option (Right to Buy) | 21,000 | - | - | Indirect |
| Jun 4, 2025 | COGT Cogent Biosciences, Inc. | Award Stock Option (Right to Buy) | 44,700 | - | - | Direct |
| Apr 29, 2025 | JBIO Jade Biosciences, Inc. | Award Stock Option (Right to Buy) | 23,017 | - | - | Direct |
| Mar 10, 2025 | VRDN Viridian Therapeutics, Inc.\DE | Award Stock Option (Right to Buy) | 42,000 | - | - | Indirect |
1-8 of 8 transactions